E J van Ameijden1, R A Coutinho. 1. Trimbos Institute (Netherlands Institute of Mental Health and Addiction), Utrecht, The Netherlands. eameijden@trimbos.nl
Abstract
OBJECTIVES: To study community wide trends in injecting prevalence and trends in injecting transitions, and determinants. DESIGN: Open cohort study with follow up every four months (Amsterdam Cohort Study). Generalised estimating equations were used for statistical analysis. SETTING: Amsterdam has adopted a harm reduction approach as drug policy. PARTICIPANTS: 996 drug users who were recruited from 1986 to 1998, mainly at methadone programmes, who paid 13620 cohort visits. MAIN RESULTS: The prevalence of injecting decreased exponentially (66% to 36% in four to six monthly periods). Selective mortality and migration could maximally explain 33% of this decline. Instead, injecting initiation linearly decreased (4.1% to 0.7% per visit), cessation exponentially increased (10.0% to 17.1%), and relapse linearly decreased (21.3% to 11.8%). Non-injecting cocaine use (mainly pre-cooked, comparable to crack) and heroin use strongly increased. Trends were not attributable to changes in the study sample. CONCLUSIONS: Harm reduction, including large scale needle exchange programmes, does not lead to an increase in injecting drug use. The injecting decline seems mainly attributable to ecological factors (for example, drug culture and market). Prevention of injecting is possible and peer-based interventions may be effective. The consequences of the recent upsurge in crack use requires further study.
OBJECTIVES: To study community wide trends in injecting prevalence and trends in injecting transitions, and determinants. DESIGN: Open cohort study with follow up every four months (Amsterdam Cohort Study). Generalised estimating equations were used for statistical analysis. SETTING: Amsterdam has adopted a harm reduction approach as drug policy. PARTICIPANTS: 996 drug users who were recruited from 1986 to 1998, mainly at methadone programmes, who paid 13620 cohort visits. MAIN RESULTS: The prevalence of injecting decreased exponentially (66% to 36% in four to six monthly periods). Selective mortality and migration could maximally explain 33% of this decline. Instead, injecting initiation linearly decreased (4.1% to 0.7% per visit), cessation exponentially increased (10.0% to 17.1%), and relapse linearly decreased (21.3% to 11.8%). Non-injecting cocaine use (mainly pre-cooked, comparable to crack) and heroin use strongly increased. Trends were not attributable to changes in the study sample. CONCLUSIONS: Harm reduction, including large scale needle exchange programmes, does not lead to an increase in injecting drug use. The injecting decline seems mainly attributable to ecological factors (for example, drug culture and market). Prevention of injecting is possible and peer-based interventions may be effective. The consequences of the recent upsurge in crack use requires further study.
Authors: Brooke S West; Daniela Abramovitz; Hugo Staines; Alicia Vera; Thomas L Patterson; Steffanie A Strathdee Journal: J Urban Health Date: 2016-02 Impact factor: 3.671
Authors: Elisabeth J Rook; Alwin D R Huitema; Wim van den Brink; Jan M van Ree; Jos H Beijnen Journal: Clin Pharmacokinet Date: 2006 Impact factor: 6.447
Authors: Alan Neaigus; Mingfang Zhao; V Anna Gyarmathy; Linda Cisek; Samuel R Friedman; Robert C Baxter Journal: J Urban Health Date: 2008-03-14 Impact factor: 3.671
Authors: Imke Schreuder; Marianne Ab van der Sande; Matty de Wit; Monique Bongaerts; Charles Ab Boucher; Esther A Croes; Maaike G van Veen Journal: Harm Reduct J Date: 2010-10-26